INTRODUCTION
A single immunoglobulin (Ig) heavy chain gene can be alternatively expressed as mRNAs for a secretory-specific (sec) or a membranespecific (mb) protein (1, 2) . Although both forms of mRNA are expressed at equal levels in early and memory stages of B-cell development, there is 20-100 times more sec-than mb-specific mRNA produced in the plasma cell (3, 4) . There is >2 kb between the promoter proximal sec poly(A) site and the downstream mb poly(A) site in the mouse Ig γ2b gene. Splicing of the γ2b encoded CH3 to M1 exons removes the sec poly(A) site from the transcript, thus allowing mb-specific mRNA to be expressed. If cleavage and polyadenylation occur first at the secretory specific poly(A) site just downstream of CH3, the CH3-M1 splice is prevented and only sec mRNA is produced. Transfection studies have shown that there is no change in splicing efficiency of a variety of constructs between early B-cells and plasma cells (5) (6) (7) (8) .
In contrast, an increase in the polyadenylation efficiency in vivo of Ig sec poly(A) sites was seen in plasma cells versus early and memory B-cells for µ and α (9,10) and γ sites (11) . Studies of polyadenylation competent extracts prepared from mouse B-cell lines representing different stages of development have shown that there is as much as an 8-fold increase in the binding of the 64 kDa subunit of CstF and the 100 kDa subunit of CPSF to input polyadenylation substrates in the plasma cell extracts as compared with the early or memory B-cell extracts (12, 13) . The increased binding occurs without a commensurate increase in the amount of either protein (12, 13 ). An increase in the efficiency of the polyadenylation reaction in plasma cells could result in a large increase in the relative amount of the sec mRNA since use of the sec poly(A) site would preclude splicing to the membrane exons. In addition, a factor was purified from early/lymphoma B-cells which accelerates the decay of Ig sec polyadenylation complexes (14) . Differential expression of the mouse γ and α Ig heavy chain genes may be solely the result of regulation of polyadenylation since transcription termination does not play a role in their expression as it does in the µ Ig gene (15) (16) (17) (18) (19) .
We previously studied the tissue specific polyadenylation of the Ig γ2b gene by making deletions and substitutions at the sec poly(A) site in constructs stably transfected into cell lines showing processing patterns like either early or plasma B-cells (11, 20) . In constructs with different 5′ proximal poly(A) sites in competition with a constant 3′ distal site, we were able to measure the relative strengths of poly(A) sites by determining the proximal to distal site use (P:D ratio). A strong site is defined here as one in which the P:D ratio exceeds 30:1 while weak sites show a much lower value (∼5:1 or less). By comparing the P:D ratio between different constructs in a given cell-type, the effect of nucleotide substitutions on the proximal poly(A) site use can be assessed. By comparing the P:D ratio between cell-types for a given construct the effect of the presence or levels of trans acting factors which act on poly(A) sites in that cell can be assessed.
Our previous studies showed that the relatively weak Ig γ2b secretory polyadenylation site was more efficiently used in plasma cells than in earlier B-cell stages. In contrast, we observed no B-cell specific regulation of the SV40 early or the γ2a membrane poly(A) sites in linked poly(A) site constructs (20) . Since the strong SV40 early and the weak, regulated Ig sec poly(A) regions *To whom correspondence should be addressed. Tel: +1 412 648 9098; Fax: +1 412 624 1401; Email: chris@hoffman.mgen.pitt.edu + Present address: Oak Ridge National Laboratory, PO Box 2008, Oak Ridge, TN 37831, USA in these constructs differ by only a small number of nucleotides in the region downstream of the proximal poly(A) addition site and at the site itself, we made substitution and alterations in these regions. These alterations result in up to 7-fold changes in the P:D ratio in a given cell type. However, these poly(A) sites, all with P:D ratios of v5:1, are used most efficiently in plasma cells. We made other constructs totally devoid of Ig sequences and show that weak α2-globin and viral poly(A) sites are also used more efficiently in plasma cells. We conclude that weak sites (P:D ratio v5:1) regardless of sequence are regulated in a B-cell stage-specific manner. This set of constructs was also analyzed in mouse L cells, a fibroblast line, in which the splicing reaction was shown to dominate over polyadenylation at the Ig γ sec poly(A) site in intact Ig constructs with splicing and polyadenylation in competition (6) . We find that weak poly(A) sites are generally less efficient in L cells than in plasma cells.
MATERIALS AND METHODS

Transfection substrates
pSm series. The 1285 nt SstI-SmaI fragment from the mouse immunoglobulin γ2b CH3-M1 intron was cloned into the SstI and SmaI site of pGEM4 (Promega). An 830 nt fragment, containing the sec poly(A) site and downstream region, was removed by KpnI digestion creating pSq∆Kpn the forerunner of pSm0. The 351 nt region downstream of the sec poly(A) signal is identical to that found in the ∆Kpn constructs from Kobrin et al. (20) and which, when part of the entire γ2b gene, directs virtually no polyadenylation on its own. Subsequent constructs were made by inserting double stranded oligonucleotides with Asp718 ends into the Asp718 (KpnI isochizomer) site within the SstI-SmaI fragment of pSq∆Kpn. The double-stranded oligonucleotide was 20 nt for pSm0* and 31 nt for all the other pSm1 or 2 constructs. Following insertion of annealed complementary oligonucleotides, the constructs were sequenced using the Genesis 2000 system (Dupont) to confirm orientation and integrity. The sequences of the top strands of the inserted oligos are shown in Figure 1 ; the bottom strands are not indicated but they all extend 4 nt to the right (5′) side with 5′-GTAC-3′. The 455 nt SstI-SmaI (lacking the KpnI-KpnI interval) fragment, but now containing the oligonucleotide, was removed from the pGEM4 constructs by digestion with EcoRI and SmaI. The fragment ends were made even by a Klenow DNA polymerase fill-in reaction and inserted into the HpaI site of the pSV2gpt Eh5a vector, which has the Ig enhancer added to pSV2gpt; addition of the enhancer increases the transfection efficiency of the plasmid in lymphocytes (11, 21) . This created the pSm series of plasmids which were stably transfected into the eucaryotic cells; the distance between the inserted poly(A) site and that of the downstream vector poly(A) site, the SV40 early site, in these constructs is 452 nt.
Constructs which were used as probes for the transfection studies were subsequently made from an ∼576 bp HinfI fragment from each individual pSm-series transfection substrate. The HinfI fragments for pSm0 and 0* are 31 and 11 nt shorter, respectively. The HinfI fragments (one for each construct in the pSm series) were gel purified, the ends made blunt and cloned into pGEM4 for use as a substrate for in vitro transcription. These HinfI fragments contain sequences upstream of the HpaI site from the pSV2gpt Eh5a, the 90 nt region upstream of and including the A2UA3 of the Ig sec site, the inserted oligonucleotide sequences plus ∼100 bp downstream of the oligomer (Fig. 2) . Orientation was determined by sequencing; the previously unsequenced interval from KpnI to SmaI in the IVS between CH3 and M1 was deposited in GenBank, accession no. Z12300. The appropriate T7 or SP6 transcription start site was used to produce anti-sense probe for T2 ribonuclease protection analyses from the HinfI clones. These probes can differentiate messages transcribed from the transfected gene from those transcribed from the endogenous γ2a gene of A20 which protects only 95 nt of shared, contiguous Ig sequence.
pglobin. The weak α2-globin poly(A) site was subcloned from pαWps (22) generously provided by Dr N. Proudfoot; the 721 nt HindIII-HpaI fragment was first inserted into the HindIII and HincII sites of pGEM3 to create p2.3. A 564 nt ApaLI-PvuII fragment, containing the α2-globin poly(A) site (sequence in Fig. 6 ), plus some of the pGEM sequence from the multicloning site to PvuII, of p2.3, was then inserted into the HpaI site of pSV2gpt Eh5a vector, creating pglobin; which was used for creating the stable transfectants of eucaryotic cells. The distance between the inserted α2-globin poly(A) site of pglobin and the downstream, vector poly(A) site is 481 nt (Fig. 7) . The p2.3 pGEM clone was digested with NarI and antisense RNA probes were made with T7 polymerase for the subsequent T2 ribonuclease protection analyses.
pgpt88 4 . The pgpt88 4 construct was produced by subcloning a minor SV40 poly(A) sequence in a tandem quadruple array, from p88 4 , provided by Roger Denome (23) . First, p88 4 was digested with SmaI and EcoRI and the ∼660 nt fragment was cloned into pGEM3Z at the SmaI and EcoRI sites to produce p3Z-88 4 . The ∼660 nt sequence of p3Z-88 4 was removed with EcoRI and SmaI, the ends made blunt with Klenow and inserted into the HpaI site of pSV2gpt Eh5a to create pgpt88 4 , used for the eucaryotic cell transfections. The distance between the first poly(A) site in pgpt88 4 and that of the SVE site of the pSV2gpt construct is 612 nt as shown in Figure 8 . For the T2 nuclease protection analyses we used p3Z-SVL/88 in which the EcoRI-SmaI fragment from pSVL/88, also provided by Roger Denome, was subcloned into the corresponding sites in pGEM3Z. The antisense probe, generated by SP6 transcripts of p3Z-SVL/88 previously digested with SalI, hybridizes with mRNA from pgpt88 4 transfectants to protect fragments indicating use of the first, i.e. proximal, poly(A) site (134 nt protected fragment) versus the use of any distal site (156 nt protected fragment) since the first site has unique 5′ sequence, BssHII-SmaI (23; R. Denome, personal communication.)
Generation and analysis of stable transfectants of mammalian cells
The mouse plasmacytoma cell line J558L is representative of a late stage or plasma B-cell line (24) . The mouse cell line A20.2J subclone #1 was used because it produces an endogenous γ2a message at 2:1 sec:mb levels (20) . A20 is representative of a memory or lymphoma B-cell, an earlier step in development than the plasma cell. Lipofectant reagent (BRL) was used to introduce pSV2gpt derived plasmid DNAs into mammalian cells following the manufacturer's recommendations. Positive transformants arose after 2-4 weeks following the mycophenolic selection schema previously described (20, 24) . Mouse L cell transfectants were selected using the conditions described for J558L cells (20) . Clones from at least three and generally four independent transfectants of Figure 1 . Oligonucleotide substitutions at the Ig γ2b secretory poly(A) site. Oligonucleotides were substituted for the mouse Ig γ2b secretory poly(A) site using the Asp718/KpnI site at the end of the normal 3′ untranslated region. The lightly shaded fragment contains the SstI site downstream of the 5′ splice site in the secretory exon 3′ untranslated region up to and including the SmaI site upstream of the M1 exon; this interval was deleted of the resident secretory specific poly(A) cleavage site and the next 830 nt of downstream region (KpnI-KpnI fragment) but still contains the Ig secretory specific poly(A) signal, indicated by the AAUAAA. Double-stranded oligos were inserted in the Asp718/KpnI site by virtue of the overlapping complementary ends; only the top strand of the oligo is shown, the bottom strand is not indicated but extends 4 nt to the right (5′) side with GTAC. Construct pSm0 contains no oligo, while pSm0* adds only the cleavage site but not the downstream GT/T-rich region. The site of poly(A) addition is indicated by the arrow above the top sequence. each cell type were grown to mass culture under conditions of drug selection and cytoplasmic poly(A) containing RNA was isolated using oligo (dT)-cellulose (Collaborative Research). Each tranfectant was analyzed in the T2 ribonuclease protection assay a minimum of three times. Because of the previously observed pleomorphic nature of the line, levels of endogenous γ2a mRNA in the individual A20 transfectants were monitored by Northern analysis and those rare clones exhibiting >3:1 sec:mb mRNA ratios were eliminated from further study. Removal of the mycophenolic selection from the clones for >5 days had no effect on the poly(A) site use (data not shown). Poly(A) site use was assayed as described previously (25) by hybridizing the cytoplasmic poly(A)+ RNAs from the transfectants with 32 P-U-labeled antisense probes generated from the pGEM clones containing the appropriate fragments. The hybridization mix was subjected to T2 ribonuclease digestion. The protected fragments were resolved on denaturing urea:polyacrylamide gels. Cells which were not transfected with the constructs show no protected fragments ( Fig. 7 and data not shown). Labeled molecular weight markers used as standards included 1 kb DNA ladder (BRL) and Marker V (Boehringer Mannheim) labeled with [ 32 P]ATP and kinase. Gels were exposed to X-ray film with an intensifier screen at -70_C for between 24 h and 5 days for the photographs. Quantitation was done on the Molecular Dynamics Phosphoimager with exposures in the linear response range of the instrument. A correction factor for the number of U residues in the sequence was applied to the promoter proximal to distal ratio. Results were analyzed using the Instat (GraphPAD Software, Inc.) Statistical Package and Microsoft Excel to determine standard deviations and standard errors of the mean. For each construct the J558L data were compared with the A20.2J data, using the Students T test, to exclude the null hypothesis, P = <0.05 and passed that test in all cases.
RESULTS
We have used an approach which assesses both the strength and the contribution to B-lineage regulated expression of sequences around the secretory specific poly(A) site of the Ig γ2b heavy chain gene by allowing it to control polyadenylation of a non-immunoglobulin gene, bacterial guanosyl phosphotransferase Figure 1 shows the constructs and oligonucleotide inserts, as well as the strategy employed in the T2 ribonuclease protection experiments. Clones used for the unique 32 P-U-labeled, anti-sense probes were prepared from HinfI subclones of each pSm construct. The distance between the inserted (proximal) poly(A) site and that of the pSV2gpt vector, the SV40 early, (distal) site, was 452 nt. Cytoplasmic poly(A)+ RNA was used for the analyses from the individual stable transfectants. Lanes 1, 2 and 3: A20 cells transfected with pSm1(Ig sec); lanes 4, 5 and 6: J558L cells transfected with pSm1(Ig sec); lanes 7 and 8: L cells transfected with pSm1(Ig sec); lanes 9 and 10: A20 transfected with pSm2(SVE); lanes 11 and 12: J558L transfected with pSm2(SVE); lanes 13 and 14: L cells transfected with pSm2(SVE). Cells which were not transfected with the constructs showed no protected fragments (data not shown).
(gpt). This gpt gene, present in the pSV2gpt based vector, confers mycophenolic acid resistance to stably transfected cells and is under the control of SV40 early promoter and polyadenylation sequences (24) . The unique HpaI site found 83 bp upstream of the vector SV40 early poly(A) site of pSV2 Eh5a was used to insert a series of mutations of the Ig γ2b secretory poly(A) site, making the pSm constructs. All splice sites are missing from this interval. The inserted sequences are shown in Figure 1 ; otherwise these constructs are identical to each other. The region downstream of the proximal poly(A) site is identical to that found in the ∆Kpn constructs (20) and which, when part of the entire γ2b gene, directs virtually no polyadenylation on its own.
Constructs were transfected into either the A20.2J line, a Balb/c mouse tumor line representative of an early or memory B-cell line, J558L, a Balb/c mouse tumor line representative of the latest stage in B-cell development, the plasma cell, or mouse L cells, a fibroblast-like line representative of the non-Ig regulated state. We analyzed poly(A)+ cytoplasmic RNA from at least three, and generally four, independent transfectants of each cell type that were stably transfected with the gpt constructs. Each transfectant was analyzed by a T2 nuclease protection assay a minimum of three times. To determine how often each of the two possible poly(A) sites had been used in mRNA processing, we set up the nuclease protection assay illustrated in Figure 2 . Transfected cell mRNAs from pSm1(Ig sec) or pSm2(SVE) constructs which have used the promoter distal, vector poly(A) site, will protect a fragment from T2 ribonuclease digestion of 576 nt. Transfected cell mRNAs which have used the promoter proximal, or oligonucleotide modified, poly(A) site will protect a fragment of 477 nt. Several representative nuclease digests are shown in Figure 2 ; pSm2(SVE), which contains the sequence from the SV40 early poly(A) cleavage site and downstream region, shows exclusive use of the promoter proximal poly(A) site versus distal site (P:D ratio &50:1), regardless of which cell was transfected. We call this site strong because of the high P:D ratio and unregulated since it shows no cell type specificity, a conclusion consistent with the observation we made previously with a similar construct (11) . In construct pSm1(Ig sec) the oligomer has the γ2b secretory-specific poly(A) site and its downstream sequence. As shown in Figure 2 and summarized in Figure 3 , in J558L transfectants of pSm1 the promoter proximal, Ig sec, poly(A) site is used about as often as the promoter distal, vector, poly(A) site in the production of poly(A)+ cytoplasmic RNAs (1:1 ratio). Therefore, the Ig sec poly(A) site of pSm1 is very weak relative to the SV40 early-like poly(A) site in pSm2. However, in A20.2J cells transfected with pSm1(Ig sec) the proximal, inserted poly(A) site is even less efficient than in the J558L cells (0.43:1 proximal to distal ratio). The regulation index (1:1 for J558L divided by 0.43:1 for A20) indicates a 2.6-fold more frequent use of the promoter proximal site in the plasma cell tumor than in the early, memory B-cell tumor. The L cell value falls between these two. Since the distance between the poly(A) sites was kept small (452 nt), the regulation index is not as large as had been previously seen with other constructs or the intact Ig gene (11, 20, 21) . The Following the T2 nuclease protection assay for each construct using 32 P-U-labeled probes, gels were dried and assayed for the amount of radioactivity in the bands representing use of the promoter proximal versus distal poly(A) sites on a Phosphoimager. The P:D site ratio was determined after applying a correction factor for the number of U-residues in a given sequence. Values shown are the average of multiple determinations per construct per cell line. Error bars indicate the range of the standard errors of the mean; where none are indicated, the S.E.M. values were too small to be seen above the bars. The pSm2(SVE) value was off scale (&50) for all three cell types and was therefore not plotted. The pSm0 and pSm0* values showed exclusive promoter distal site use and were also not plotted.
small distance minimizes the possibility of transcription termination which generally occurs >1 kb downstream of a poly(A) site in this system (15, 16) .
As shown in Figure 4 , construct pSm0, which lacks any poly(A) site or downstream region, shows only the 545 nt protected fragment in the nuclease protection assay in all cell types; the full length protected fragment is smaller than the one in pSm1(Ig sec) or pSm2(SVE) because of the missing 31 nt of sequence. A similar result, exclusive use of the vector poly(A) site, was obtained with pSm0*(containing the cleavage site but no downstream sequence), data not shown. Thus we conclude that in the absence of an inserted site and a GT-rich downstream element there is exclusive use of the promoter distal, vector poly(A) site in these two constructs.
When we compared the sequences of the SV40 early poly(A) site downstream of the poly(A) cleavage site in pSm2 to the Ig sec downstream consensus in pSm1 (Fig. 1) , we noted that a 5 nt TGGTT core element is identical between the two sequences, whereas flanking nucleotides differ. Earlier work (26, 27) showed that mutations within the 5 nt core region of the SV40 site drastically reduced site efficiency so that the region was not altered in our constructs. We made mutations in the regions flanking the core in order to test the possible contribution of individual dinucleotides to the efficiency of the sites in our assay and to the tissue specific regulation of polyadenylation. The dinucleotide 5′ of the TGGTT core was changed from CC to TG in the construct pSm1,5′. The dinucleotide 3′ of the core was changed from CT to TG in the construct pSm1,3′ and both dinucleotides were altered in the construct pSm1,5′3′.
As shown in Figure 4 and summarized in Figure 3 , the three constructs pSm1,5′, pSm1,3′ and pSm1,5′3′ have differences in Figure 1 shows the constructs and oligonucleotide inserts. The strategy employed in the T2 ribonuclease protection experiments is the same as that shown in Figure 2 , with the exception that the pSm0 fragments were all 31 nt shorter because of the missing oligonucleotide. Lanes 1-6, pSm0 construct: lanes 1 and 2, A20 transfectants; lanes 3 and 4, J558L transfectants; lanes 5 and 6, L cell transfectants. Lanes 7-12, pSm1,5′ construct: lanes 7 and 8, A20 transfectants; lanes 9 and 10, J558L transfectants; lanes 11 and 12, L cell transfectants. poly(A) site strengths, but all still show B-lineage regulation which is as good or better than with pSm1, the construct with the unaltered γ2b poly(A) site and downstream element. The proximal to distal poly(A) site usage in L cells for pSm1,5′ and pSm1,3′ are intermediate between the J558L and A20 cell values, while for pSm1,5′3′ they exceed the J558L (plasma cell) values slightly.
Since the dinucleotide altered constructs still contain the Ig sec poly(A) cleavage site, we wondered whether the inclusion of the site itself had led to the regulation observed. To address this question we assayed two constructs, one of which links the immunoglobulin cleavage site with the SV40 downstream region (pSm1,2) and the other which links the SV40 poly(A) site with the immunoglobulin downstream consensus (pSm2,1). In the data shown in Figure 5 , both constructs show less proximal poly(A) site use than pSm2 (SVE-like). But, when the use of the site in the J558L cells is compared with that in A20 cells (Fig. 3 ) the value in plasma cells (J558L) exceeds that seen in the early, memory B-cell (A20). The L cell value is the same or lower than that seen with the A20 cells. From these observations, we conclude that the strength of the pSm2 sequence comes from both the SV40 early poly(A) addition site itself and the SV40 early downstream element acting in concert. These contributions to strength are more than additive, indicating a cooperative interaction with the polyadenylation machinery. In Figure 5 . T2 ribonuclease protection analysis of pSm1,2 and pSm2,1. The map in Figure 1 shows the constructs and oligonucleotide inserts. The strategy employed in the T2 ribonuclease protection experiments is the same as that shown in Figure 2 . Lanes 1-6, pSm1,2 construct: lanes 1 and 2, A20 transfectants; lanes 3 and 4, J558L transfectants; lanes 5 and 6, L cell transfectants. Lanes 7-12, pSm2,1 construct: lanes 7 and 8, A20 transfectants; lanes 9 and 10, J558L transfectants; lanes 11 and 12, L cell transfectants. Cells which were not transfected with the constructs showed no protected fragments (data not shown).
addition, the similar B-lineage regulation for pSm1,2 and pSm2,1, taken together with those of the previous constructs, lead us to conclude that none of the nucleotides in the 26 nt stretch which we have mutated abrogate regulation. Therefore, we conclude that the weakness of the site and not the exact sequence is what is important for regulation.
To extend the conclusion that the weakness (low P:D ratio) and not the exact sequence at a poly(A) site is important for regulation, we analyzed two constructs totally lacking Ig sequences in our linked poly(A) assay system. In the first construct ∼480 nt of sequences from the weak poly(A) site of the α2-globin gene (22) were inserted into the HpaI site of pSV2gpt upstream of the vector's SV40 early poly(A) site. There is little similarity between the Ig sec and α2-globin sequences (data not shown). The portion of the sequence of the α2-globin gene surrounding the poly(A) cleavage site is compared with that in the Ig secretory site of pSm1 in Figure 6 . The only obvious similarity between the two, besides the AATAAA, is in the region downstream of the poly(A) cleavage site. The position of this CCT(G) n TTCT element is from +8 to +16 downstream of the cleavage site in the Ig sequence and from +12 to +21 in the α2-globin sequence. Transfectants of the α2-globin constructs in J558L, A20 and L cells were analyzed by a nuclease protection assay as illustrated in Figure 7 . As shown in a typical assay, the 185 nt band representing the use of the promoter proximal (globin) site is more intense in the J558L cells than the band representing mRNAs that have the promoter distal (SV40 early, vector) poly(A) site. The results from several determinations with all three cell types are compiled and shown in Figure 3 . The plasma cells (J558L) show a 5:1 P:D poly(A) site ratio; in A20 it is 1.75:1 and the L cell value is intermediate between these two. The regulation index (J558L value divided by A20 value) is 2.8, a value as good or better than that seen with pSm1, the Ig secretory sequence. The similarity between α2-globin and the Ig γ2b sec sequences are minimal and yet the plasma cell acts on the α2-globin sequences with an efficiency that is greater than that seen in A20 (early/memory) B-cells or the L cells. While the protected fragment in lane 3 appears shorter than those in lanes 1, 2 and 4-6 on this gel, that was not the case in the other experiments run with these cells.
In the next construct we used a fragment of ∼600 nt containing four repeats of an 88 bp AATAAA-containing DNA fragment from the SV40 early region (88 signal) shown previously to be a weak poly(A) signal (23) . This poly(A) site lacks a recognizable GT-rich or T-rich downstream element, although as shown in Figure 6 , there is a pyrimidine-rich track upstream of the cleavage site. The interval from p88 4 was subcloned into the HpaI site of pSV2gpt Eh5a, upstream of the vector SV40 early poly(A) site (Fig. 8) . A nuclease protection assay was set up using another clone which distinguishes between use of the first (proximal) versus all distal sites based on the unique size of the protected fragments; a previous study showed that in Cos-1 cells the first of the weak poly(A) sites in this array was used more often than the others (23) . In a representative nuclease protection assay, shown in Figure 8 , the 134 nt band representing use of the promoter proximal site was more intense relative to the 156 nt band representing use of the distal site in the J558L cells. The reverse is true in the A20 cells. The combined results from several experiments are shown in Figure 3 . Once again, as with all the other constructs tested, poly(A) addition at the first site was much more frequent in the J558L (plasma cells) than in the A20 (lymphoma or memory B) cells. We therefore conclude that the B-lineage regulation of poly(A) site use occurs independent of sequence and seems to be effective on relatively weak poly(A) sites in vivo.
DISCUSSION
In this study, poly(A) site strength or weakness is assessed by comparing the amount of use of the promoter proximal versus promoter distal poly(A) sites, the P:D ratio, in the absence of a 4 site, based on a unique 88 bp fragment of DNA from SV40. The pSm1(Ig sec) region is derived from the sequencing we did on our clones and extends to the SmaI site (not all shown); the full sequence of the γ2b IVS was deposited in GenBank, accession no. Z12300. The region of pSm1(Ig sec) that is underlined is that which is derived from the 31 nt oligonucleotide insertion, see Figure 1 . The portion of pSm1(Ig sec) in the bold type, from +8 to +16 with respect to the poly(A) cleavage site, shows some similarity with the region from +12 to +21 in α2-globin also in bold type. competing splicing reaction by using mutations in the region around the mouse Ig γ2b sec poly(A) site. To determine the extent of B-lineage regulation, constructs were stably transfected into mouse cell lines representing different B-cell stages or into fibroblasts (L cells). In pSm2, a γ2b sec poly(A) site was modified, just at the cleavage and downstream region, to look similar to that part of the SV40 early site; when this site was in the promoter proximal location it was used predominantly, with a P:D ratio &50:1, and was therefore a 'strong' site in our assay. The SV40 early-like poly(A) site of pSm2 was used to the same same extent regardless of cell type transfected. All the other modified γ2b sec proximal poly(A) sites were used to a higher degree in the plasma cell (J558L) than in the early, memory or lymphoma cell (A20); plasma cells were more efficient at polyadenylation than L cells for all but one of these constructs. This increased efficiency in plasma cells was also seen in constructs totally lacking Ig sequence but instead containing ∼480 nt of the human α2-globin poly(A) site or a fragment of ∼600 nt with a minor SV40 poly(A) sequence repeated four times. We therefore conclude that cis acting sequences are not responsible for the observed increase in proximal poly(A) site use in plasma cells. Instead, it is the weakness of a site which allows it to be acted upon in vivo by the increased efficiency of the polyadenylation machinery in plasma cells. Having a very strong site (like that in pSm2) proximal to the promoter, allows that site to be used to such a great extent relative to the downstream site that an increase in efficiency may not be observable; thus, regulation can be seen only on weaker sites. In contrast, in vitro, with sites that are not tandemly linked, we can see an increase in the UV-cross linking of constitutive polyadenylation factors from plasma cell extracts to both weak Ig secretory poly(A) sites and a variety of strong sites (12, 13) . This indicates that all sites are enhanced in plasma cells but weak sites which are promoter proximal are the ones which benefit most from this type of control mechanism in vivo. Taken together, the evidence indicates that trans acting factors change during differentiation to plasma cells and Ig secretory mRNA expression; this transition may either involve alterations to generic polyadenylation factors or induction of plasma cell specific factors to increase polyadenylation efficiency. The amount of 64 kDa CstF and 100 kDa CPSF essential polyadenylation factors do not change between the cells Figure 8 . T2 ribonuclease protection analysis of pgpt88 4 constructs. A minor SV40 poly(A) sequence known as 88, was cloned from p88-4, in a tandem quadruple array, into the same vector used for the pSm and pglobin analyses. The distance between the first 88 poly(A) site and the distal, vector poly(A) site is 612 nt. The distance between 88 sites is 160 nt. The 600 nt antisense probe, generated by SP6 transcripts of p3Z-SVL/88 previously digested with SalI, hybridizes with mRNA from pgpt88 4 transfectants to protect fragments indicating use of the first, i.e. proximal, poly(A) site (134 nt protected fragment) versus the use of any distal site (156 nt protected fragment).
(12,13, and data not shown). Differences in growth rates cannot account for the differences we see since all three cell types grow with approximately the same doubling time and all transfected cells were harvested in the exponential phase of growth.
The distance between the poly(A) sites was kept to a minimum in all our constructs (452, 481 and 612 nt), so that transcription termination, which generally occurs >1 kb downstream of most poly(A) sites, would not be a confounding variable in the poly(A) site choice assay. With the short distance between sites the difference in the proximal to distal ratios in J558L versus A20 is not as large as has been previously seen with other constructs or the intact Ig gene. Even a small change in polyadenylation efficiency can result in a large increase in the use of the secretory specific site in the intact Ig gene because of the large (>2 kb) distance between the poly(A) sites, which would allow polyadenylation factors to work on the first (sec) site before the second (mb) site is even transcribed by the slowly advancing RNA Pol II.
Using constructs with competing splice versus polyadenylation sites, it has been shown that non-Ig RNA can be alternatively processed in a B-lineage regulated manner (5). Our results agree with those and extend the findings by showing that regulation is seen at non-Ig poly(A) sites alone, in the absence of a competing splice site, and by showing that sequences at the cleavage site and downstream region, while influencing poly(A) site strength, all show B-lineage regulated expression.
When Brown and Morrison looked at mouse L cells transfected with the intact and two different mutant Ig γ2b genes, with splicing and polyadenylation sites in competition, the constructs produced heavy chain mRNAs with patterns, on the aggregate, of promoter proximal (sec) poly(A) site use intermediate between that seen in the A20 and J558L cell transfectants (6) . With our constructs the L cells show use of the promoter proximal weak poly(A) sites at a level intermediate between that in the A20 and J558L transfectants, suggesting that the relative weakness of the γ2b sec poly(A) in L versus plasma cells caused the sec site to be passed over in the L cells in the Brown and Morrison constructs.
The constructs pSm1,2 and pSm2,1 are at least as regulated as pSm1(Ig sec) but are much stronger in comparison. The increase in site strength relative to pSm1(Ig sec), in this case, is due to the inclusion of SV40-like sequences both at the cleavage site and in the downstream region. The effect of having both SVE elements in pSm2 (SVE-like) is more than additive, indicating a cooperativity between the cleavage site and the downstream element. Meanwhile, the constructs pSm1,3′, pSm1,5′, and pSm1,5′3′ have substitutions in the Ig secretory specific downstream consensus which make them more similar to the stronger SV40 early downstream region of pSm2. However, pSm1,3′ is unexpectedly weaker than pSm1(Ig sec), even while extending the run of GT sequences. The mutation does interrupt a pyrimidine run, which, coupled to the TGGTT core element, may be important for efficient poly(A) site use. The construct pSm1,5′3′ has a downstream region that is very similar to pSm1,2 except for three out of the last four nucleotides. The weak use of the proximal poly(A) site in pSm1,5′3′ may reflect the complex nature of regulation at this site and of the trans acting factors which could bind; the sequences from +17 to +21 downstream of the poly(A) cleavage site must play a role in these interactions.
An intact Ig γ or µ gene has a secretory terminal exon with a 3′ splice site, 360 nt of coding sequence, a 5′ splice site, ∼100 nt of 3′ UTR and a poly(A) site. A weak poly(A) site at the end of the terminal secretory exon is needed to maintain regulated processing of that exon (11, 16, 21) . While constitutive splicing seems unaffected between B-cell stages (5) (6) (7) (8) , the interplay of splicing and the poly(A) site during exon scanning must be altered if poly(A) site efficiencies change. Understanding of the interaction between the 5′ splice site and the polyadenylation reaction is just beginning to emerge (28) (29) (30) . Continued study of the Ig gene and its regulation may help us understand regulated polyadenylation, exon definition and the interplay of both.
